Proem Advisors’s Hinge Health HNGE Stock Holding History

Proem Advisors’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$2.07M	–	55
2025 Q2	$2.07M	Buy	+40,000	New	+$1.62M	0.27%	38

Other funds holding HNGE

IHG

Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Proem Advisors's HNGE Position: Q3 2025 in Review

Proem Advisors sold out of Hinge Health (HNGE) in Q3 2025, closing a stake of 40,000 shares — an estimated $2.07M sold.

Proem Advisors first reported a position in HNGE in Q2 2025 and held it in 1 quarter. The position peaked at $2.07M in Q2 2025. 146 funds tracked by Wall St. Rank hold HNGE as of Q3 2025.

Proem Advisors reported no remaining Hinge Health position as of Q3 2025 after selling out during the quarter.
Proem Advisors sold 40,000 Hinge Health shares in Q3 2025, an estimated $2.07M.
Proem Advisors first reported a position in Hinge Health in Q2 2025 and held it in 1 quarter.
Proem Advisors's Hinge Health position peaked at $2.07M in Q2 2025.
146 funds tracked by Wall St. Rank held Hinge Health as of Q3 2025.

Based on Proem Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.